**Core Concept**
Rheumatic heart disease is a complication of rheumatic fever, an autoimmune response to group A beta-hemolytic streptococci (GABHS) infection. The condition involves the formation of antibodies against various Streptococcal antigens, leading to inflammation and damage to the heart valves.

**Why the Correct Answer is Right**
The production of antibodies against phenolic glycolipid (PGL-1) is a specific marker for rheumatic heart disease. PGL-1 is a cell wall component of GABHS that triggers an autoimmune response in susceptible individuals. The resulting antibodies against PGL-1 contribute to the development of rheumatic heart disease by facilitating the deposition of immune complexes on the heart valves, leading to inflammation and tissue damage. This process is a key component of the pathogenesis of rheumatic heart disease.

**Why Each Wrong Option is Incorrect**
* **Option A:** Antibodies against streptolysin O are associated with acute rheumatic fever, but not directly with rheumatic heart disease.
* **Option B:** Antibodies against erythrogenic toxins are responsible for the rash in scarlet fever, but not specifically related to PGL-1 or rheumatic heart disease.
* **Option D:** Antibodies against hyaluronidase are involved in the pathogenesis of rheumatic fever, but not specifically with PGL-1.

**Clinical Pearl / High-Yield Fact**
Rheumatic heart disease is a preventable condition, and early recognition and treatment of streptococcal pharyngitis with penicillin can significantly reduce the risk of developing this condition.

**Correct Answer: C. Rheumatic heart disease.**